A closer look at the technologies used by Relistor
Relistor
Manufacturing · 201-500 Employees
View Company Info for Free
Overview
Phone Number
(800) 321-4576Website
www.relistor.comRevenue
$70 MillionIndustry
About Relistor
OIC Medication offers RELISTOR® (methylnaltrexone bromide), a prescription medication specifically designed to treat Opioid-Induced Constipation (OIC) in patients experiencing constipation due to opioid pain medications. The product is available in two formulations, tablets and subcutaneous injections, targeting adults with chronic non-cancer pain or those with advanced illness. The company aims to provide effective relief for patients who may not respond to over-the-counter laxatives and require targeted treatment for OIC. Their services include resources for healthcare professionals and patients to enhance understanding of OIC and treatment options.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Relistor
Compare insights from companies similar to Relistor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Relistor
$70M
201-500
Private
-
-
N/A
Relistor Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Relistor
Sign Up For FreeTo access detailed company insights
OIC Medication offers RELISTOR® (methylnaltrexone bromide), a prescription medication specifically designed to treat Opioid-Induced Constipation (OIC) in patients experiencing constipation due to opioid pain medications. The product is available in two formulations, tablets and subcutaneous injections, targeting adults with chronic non-cancer pain... Read More
